Hybio Pharmaceutical Co., Ltd.
300199
주식 순위
#4739
Established in 1998 and headquartered in Shenzhen, China, Hybio Pharmaceutical... Established in 1998 and headquartered in Shenzhen, China, Hybio Pharmaceutical Co., Ltd. specializes in the global research, development, manufacturing, and commercialization of therapeutic peptide active pharmaceutical ingredients (APIs) and polypeptide medications. Its diverse product range addresses therapeutic needs such as diabetes (including liraglutide, semaglutide, and exenatide), gastrointestinal and metabolic disorders (with examples like terlipressin, desmopressin, and linaclotide), as well as applications in obstetrics and gynecology (featuring ganirelix, cetrorelix, and atosiban). Additionally, the company supplies custom peptides and provides essential working standards for peptide APIs and their impurities, offering comprehensive support for development initiatives. Beyond products, Hybio extends its expertise through Contract Research Organization (CRO) and an extensive Contract Development and Manufacturing Organization (CDMO) platform. This platform covers peptide API synthesis and purification process optimization, finished dosage form conceptualization, reference standard preparation and rigorous qualification, detailed impurity and product quality analysis, Good Manufacturing Practice (GMP) systems adhering to both EU and FDA benchmarks, and comprehensive regulatory and dossier support for both international and Chinese markets.
주가
$3.69
시가총액
$3.11B
변동 (1일)
-7.75%
변동 (1년)
21.56%
국가
CN
거래 Hybio Pharmaceutical Co., Ltd. (300199)
카테고리
Healthcare
Hybio Pharmaceutical Co., Ltd. (300199)의 주식 분할 이력
Hybio Pharmaceutical Co., Ltd. 주식 (심볼: 300199)은 총 3회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Apr 14, 2015에 발생했습니다.
May 17, 2012 이전에 매수한 300199 주식 1주는 현재 8주의 300199 주식에 해당합니다.
가장 최근의 분할은 Apr 14, 2015에 발생했습니다.
May 17, 2012 이전에 매수한 300199 주식 1주는 현재 8주의 300199 주식에 해당합니다.
주식 분할 목록
| 연도 | 주식 분할 | 배수 | 누적 배수 |
|---|---|---|---|
| 2015-04-14 | 2:1 | x2 | x8 |
| 2013-04-26 | 2:1 | x2 | x4 |
| 2012-05-17 | 2:1 | x2 | x2 |
유사 기업 또는 경쟁사의 주식 분할
| 회사 | 주식 분할 횟수 | 누적 배수 | 국가 |
|---|---|---|---|
| 0 | - |
DE
|
|
| 2 | x2 |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
